Moolec Science SA (MLEC) vs VivoSim Labs (VIVS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Moolec Science SA is the larger company by market cap ($3.0 million vs $2.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MLEC | VIVS |
|---|---|---|
| Share price | $4.19 | $0.1772 |
| Market cap | $3.04M | $2.94M |
| 1-day change | -12.89% | -7.47% |
| EPS (TTM) | $-199.02 | $-4.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.22 | $3.41 |
| 52-week low | $3.08 | $0.17 |
| Distance from 52-week high | -81.96% | -94.80% |
| Average volume | 17.09K | 5.85M |
| Shares outstanding | 726.12K | 16.59M |
| Employees | — | 15 |
| Sector | Finance | Health Care |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Moolec Science SA in Finance and VivoSim Labs in Health Care.
About Moolec Science SA
MLEC stock →Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas.
Finance · Blank Checks
About VivoSim Labs
VIVS stock →VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 15 employees
MLEC vs VIVS FAQ
Which is bigger, Moolec Science SA or VivoSim Labs?
Moolec Science SA (MLEC) is larger, with a market capitalization of $3.04M compared with $2.94M for VivoSim Labs (VIVS).
Are Moolec Science SA and VivoSim Labs in the same industry?
No. Moolec Science SA is in the Finance sector, while VivoSim Labs is in Health Care.